AstraZeneca PLC (LSE: AZN) is a Healthcare company,
ranked #5,053 of 6,775 companies globally and #64 of 98 in United Kingdom on PositoAI,
with a Positivity Score of 18,527.
Its market capitalisation is ₹25.46 lakh Cr (£201.31B), P/E ratio is 26.0 and P/B ratio is 5.36.
It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.
For financial statements, ratio trends and score history, Go Deep →
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze, Qtern, Wainua, Byetta, Lokelma, Seloken ZOK, Toprol-XL, Betaloc ZOK, XIGDUO, Accolate, Accoleit, Vanticon, Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Pulmicort Turbuhaler, Symbicort Turbuhaler, Airsupra, Bricanyl Turbuhaler, Fasenra, Rhinocort, Tezspire, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Saphnelo, Breztri Aerosphere, Duaklir Genuair, Pulmicort Respules, and Symbicort pMDI. It also provides Beyfortus, Kavigale, Evusheld, Fluenz/FluMist, Synagis, Kanuma, Ultomiris, Koselugo, Voydeya, Soliris, Strensiq, Nexium, and other medicines. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies for rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the Americas, rest of Europe, Asia, Africa, and Australasia. It has a strategic agreement with Tempus and Pathos to develop the multimodal foundation model in oncology; CSPC Pharmaceutical Group Limited to advance the discovery and development of oral candidates, with the potential to treat diseases across multiple indications; Nucs AI Inc. to develop AI-driven Response Prediction for Therapeutic Radioconjugates; and Carterra, Inc. to advances lab-in-the-loop drug discovery through new scientific research collaboration. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
P/B Ratio5.36
P/E Ratio26.0
D/E Ratio0.64
ROE21.96%
Owes vs Owns ?0.57× Moderate$0.57 owed for every $1 it owns · balance sheet Jun 2026
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin,…
What is AstraZeneca PLC's P/E and P/B ratio?
AstraZeneca PLC has a P/E ratio of 26.0 and a P/B ratio of 5.36.
What is AstraZeneca PLC's debt-to-equity ratio?
AstraZeneca PLC has a debt-to-equity ratio of 0.64.
How much does AstraZeneca PLC owe compared with what it owns?
AstraZeneca PLC owes $0.57 for every $1 it owns (balance sheet Jun 2026), which is moderate.
What is AstraZeneca PLC's Positivity rank?
AstraZeneca PLC is ranked #5,053 of 6,775 companies globally and #64 of 98 in United Kingdom on PositoAI, with a Positivity Score of 18,527.
Does AstraZeneca PLC have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for AstraZeneca PLC.
Where can I read the latest news about AstraZeneca PLC?
Recent headlines about AstraZeneca PLC from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does AstraZeneca PLC have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of AstraZeneca PLC's current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.
0 / 1000
🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.
Disclaimer —
PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.